Silver Book Fact

Increased use of medical technology, like colonoscopy and sigmoidoscopy for colon cancer screening, could save $178.2 billion between 2010 and 2035.

Health Savings: Medical technology and the economic burden of disease. http://assets1b.milkeninstitute.org/assets/Publication/ResearchReport/PDF/HealthySavings.pdf. Published 2014

Reference

Title
Health Savings: Medical technology and the economic burden of disease
Publisher
Milken Institute
Publication Date
Published 2014
Authors
Chatterjee, A, J King, S Kubendran, and R DeVol
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • After one year, 73 percent of non-small-cell lung cancer patients with the EGFR genetic mutation who were treated with a tyrosine kinase inhibitor had survived, compared to 15 percent who…  
  • The 5-year survival rate for localized breast cancer, is 98%–an 18% increase since the 1950s.  
  • According to the Pharmaceutical Research and Manufacturers of America, a medicine in development that is a monoclonal antibody, targets the epidermal growth factor receptor. Because cancer cells can become…  
  • Widespread use of telomerase inhibitors could result in a 50% cure rate and a 25% prolongation of life for 50% of eligible patients with solid tumors.  
  • A modest 1% reduction in cancer mortality would be worth close to $500 billion. A cure for cancer (if one is feasible) would be worth around $50 trillion.